Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Pyridam Farma Tbk (PYFA) vs Mizuho Leasing Indonesia Tbk. (VRNA)

Pyridam Farma TbkTrading
Mizuho Leasing Indonesia Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Pyridam Farma Tbk dan Mizuho Leasing Indonesia Tbk.: Pyridam Farma Tbk diperdagangkan di Rp214 (kapitalisasi pasar 2,31 T, volume 24 jam 10,47 jt), sedangkan Mizuho Leasing Indonesia Tbk. diperdagangkan di Rp76 (kapitalisasi pasar 432,24 M, volume 24 jam 286,8 rb). Perbedaan utamanya: Pyridam Farma Tbk jauh lebih besar — sekitar 5,3× kapitalisasi pasar Mizuho Leasing Indonesia Tbk., dan Pyridam Farma Tbk lebih aktif diperdagangkan (10,47 jt vs 286,8 rb). Mana yang lebih baik tergantung tujuan investasimu.

PYFAVRNA
Kapitalisasi Pasar
2,31 T432,24 M
Volume
10,47 jt286,8 rb
Lot
104,73 rb2,87 rb
Perputaran
2,2 M22,19 jt
Harga Rata-rata
209,7177,35
Nilai Transaksi
2,2 M22,19 jt
Harga Ekuilibrium Indikatif
21476
Volume Ekuilibrium Indikatif
10,89 rb5 rb

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

PYFA
Lihat detail
VRNA
Lihat detail

Tentang Pyridam Farma Tbk

PT. Pyridam Farma Tbk. Founded in Jakarta based on Limited Company Act on November 27th 1976 and start the commercial operation since 1978 which conduct in pharmaceutical business.On its first establishmnent, the corporate produce & distribute medicine products for livestock & pet.. Since 1985 the corporate develop pharmacy division which emphasize produce and distribute health product for human and for livestock held by veterinary division.

Selengkapnya di halaman PYFA

Tentang Mizuho Leasing Indonesia Tbk.

PT Verena Oto Finance (the Company) was established under its original name of PT Maxima Perdana Finance base on notarial deed No.43 of Mrs Sri Nanning, S.H, dated on Jul 21, 1993. The Companys articles of association has been amended several times, most recently by notarial deed No. 32 of Fathiah Helmi, S.H., dated Mar 26, 2007, concerning among others, the change in the Companys name, increase authorized, change in par value, and increase paid-up capital.

Selengkapnya di halaman VRNA